☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Endocrine Therapy
Henlius and Sermonix Partner to Develop Lasofoxifene for Breast Cancer
January 11, 2024
Novartis Reports Results of Kisqali (ribociclib) + Endocrine Therapy in P-III MONALEESA trials for (HR+/HER2-) Advanced Breast Can...
December 11, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.